Ruzetuoheti Yiminniyaze (Yiminniyaze Ruzetuoheti)

Years Active: 2022-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Ning Zhu, Daibing Zhou, Ruyu Yuan, Ruzetuoheti Yiminniyaze, Jing Li, Xiujuan Zhang, Sheng-Qing Li
Identification and comparison of Chlamydia psittaci, Legionella and Mycoplasma pneumonia infection. The clinical respiratory journal (2023)
Jing Wang, Shuanghui Li, Xiujuan Zhang, Ning Zhu, Ruzetuoheti Yiminniyaze, Liang Dong, Chengwei Li, Wumaier Gulinuer, Jingwen Xia, Jing Li, Daibing Zhou, Xinning Liu, Youzhi Zhang, Yuanyuan Zhang, Sheng-Qing Li
Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling. Thoracic cancer 13 (21) (2022)
Ruzetuoheti Yiminniyaze, Xiujuan Zhang, Yuanyuan Zhang, Kun Chen, Chengwei Li, Ning Zhu, Daibing Zhou, Jing Li, Yuhai Zhang, Shengqing Li
Diagnostic efficiency and safety of rapid on-site evaluation combined with CT-guided transthoracic core needle biopsy in suspected lung cancer patients. Cytopathology : official journal of the British Society for Clinical Cytology 33 (4) (2022)
Ruzetuoheti Yiminniyaze, Xiujuan Zhang, Ning Zhu, Jing Wang, Chengwei Li, Gulinuer Wumaier, Daibing Zhou, Jing Li, Jingwen Xia, Youzhi Zhang, Liang Dong, Yuanyuan Zhang, Shengqing Li
EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma. Cancer medicine (2022)

Ruzetuoheti Yiminniyaze.css-eqlu8i{font-size:small;padding-left:4px;} (Yiminniyaze Ruzetuoheti)